Class II
Terminated
Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.05mg/0.03 mg, 0.075mg/0.04mg, and 0.125mg/0.03mg, packaged in 1 Wallet of 28 Tablets (NDC 68180-857-11), 3 Wallets of 28 Tablets Each per carton (ND…
Why: Failed Content Uniformity Specifications: Out Of Specification test results observed for content uniformity.
- Company
- Lupin Pharmaceuticals Inc.
Baltimore, MD, United States - Reported
- Mar 18, 2020
- Recall started
- Mar 9, 2020
- Ended
- May 25, 2021
- Where sold
- Nationwide in the USA and Puerto Rico.
- Amount
- 9,897 cartons
- Full product description
- Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.05mg/0.03 mg, 0.075mg/0.04mg, and 0.125mg/0.03mg, packaged in 1 Wallet of 28 Tablets (NDC 68180-857-11), 3 Wallets of 28 Tablets Each per carton (NDC 68180-857-13); Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) - 454775, INDIA.
- Lots / codes affected
- Lot #: L800951, Exp July 2020
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.